Pathology
Novel Blood-Based Test Bolsters MRI-Based Prostate Cancer Screening
Prostate cancer does not usually cause any symptoms until the cancer has grown large enough to put pressure on the tube that carries urine from the bladder out of the penis (urethra). Symptoms of prostate cancer can include: needing to urinate more frequently, often during the night needing to rush to the toilet. More...23 Aug 2021
Key Factors Signal Infection Risk in Alcoholic Hepatitis
Alcohol-associated hepatitis (AAH) is a severe form of liver injury with mortality as high as 30%-40% at 90 days. As a result of altered immune function in AAH, bacterial infections are common and are associated with poor outcomes. More...17 Aug 2021
Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and genetically heterogeneous malignancies, characterized by distinct prognoses based upon primary tumor localization, functionality, grade, proliferation index and diverse outcomes to treatment. More...13 Aug 2021
Multitarget Fecal Immunochemical Test Validated for Colorectal Cancer
Colorectal cancer (CRC) starts in the colon or the rectum. These cancers can also be called colon cancer or rectal cancer, depending on where they start. Colon cancer and rectal cancer are often grouped together because they have many features in common. More...08 Aug 2021
CSF Conversion Assay Identifies Lewy Body Disease Cognitive Impairment
Lewy body dementia, also known as dementia with Lewy bodies, is the second most common type of progressive dementia after Alzheimer's disease. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control). More...08 Aug 2021
Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes
Colorectal cancer (CRC) is the fourth most common cancer and the second-leading cause of cancer-related death in the USA. Approximately 15%-25% of patients present with metastatic disease upon diagnosis, and approximately 50% of patients with early-stage disease develop metastases. More...06 Aug 2021
Diagnostic Biomarker MMP-13 Explored for Cutaneous Squamous Cell Carcinoma
Cutaneous basal cell carcinoma (cBCC) and cutaneous squamous cell carcinoma (cSCC) account for approximately 80% and 20% of non-melanoma skin cancer (NMSC), respectively Although the majority of cSCCs are successfully eradicated by surgical excision, a subset of cSCC possesses features associated with a higher likelihood of recurrence, metastasis, and death. More...27 Jul 2021
.jpg)
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Repetitive Pipette
VWR® Stepper Pro
In Other News
Immunoassays Compared for Serum HE4 Estimation for Ovarian Cancer
Preemies' Blood Type Tied to Risk for Necrotizing Enterocolitis
Telomerase Reverse Transcriptase Protein Expression Evaluated for Melanomas
Electronic Nose Sensor Accurately Detects Ovarian, Pancreatic Cancers
Protein Biomarker Helps Diagnose Pancreatic Cancer
Biomarkers Diagnose and Predict Acute Pancreatitis
Respiratory Syncytial Virus Bronchiolitis Has Different Subtypes
Hyperglycemia Evaluated as a Risk Factor in Pancreatic Cancer
Genetic Variants Associated with Unexplained Sudden Cardiac Death
CtDNA Analysis Assesses Early Relapse Detection in Colorectal Cancer
Liquid Biopsies Detect Pediatric Bone Tumors Based on Epigenetic Profiles
Genomic Differences Cause Racial Disparities in Prostate Cancer
Intraoperative Frozen Section Detect Acute Invasive Fungal Rhinosinusitis
Analytic Validation and Clinical Utilization of Comprehensive Genomic Profiling Test
Colorectal Cancer Relapse Predicted by ctDNA Clearance
Jagged Ends of Urinary Cell-Free DNA Assessed in Bladder Cancer Detection
Jagged Ends of Urinary Cell-Free DNA Assessed in Bladder Cancer Detection
Loss of Function Mutations in GEMIN5 Cause a Neurodevelopmental Disorder
Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn’s Disease
Rapid, Direct-to-Digital Prostate Biopsy Pathology Evaluated
Developed Immunoassay Predicts Benefits of Anti-PD-1 Therapy in NSCLC
Holographic Histopathology Enables Fast, Precise Diagnostics
Genetic Background and Clinicopathologic Features Established for Adult-Onset Nephronophthisis
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
